Spruce Biosciences Inc. (SPRB)
0.37
-0.00 (-0.38%)
At close: Jan 15, 2025, 3:59 PM
0.36
-1.49%
After-hours Jan 15, 2025, 04:27 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -47.92M | -46.18M | -42.29M | -29.54M | -13.09M | -9.86M |
| Depreciation & Amortization | 70.00K | 74.00K | 68.00K | 36.00K | 12.00K | 1K |
| Stock-Based Compensation | 4.62M | 3.63M | 3.96M | 755.00K | 196.00K | 101.00K |
| Other Working Capital | 8.45M | 2.53M | 806.00K | -2.57M | 489.00K | -511.00K |
| Other Non-Cash Items | -404.00K | -340.00K | 313.00K | 66.00K | 446.00K | -1.59M |
| Deferred Income Tax | n/a | n/a | 121.00K | n/a | -446.00K | n/a |
| Change in Working Capital | 10.36M | 1.13M | 1.96M | 1.16M | 263.00K | 1.19M |
| Operating Cash Flow | -33.27M | -41.68M | -35.88M | -27.52M | -12.62M | -8.57M |
| Capital Expenditures | -7.00K | -8.00K | -93.00K | -74.00K | -4.00K | n/a |
| Acquisitions | n/a | -23.70M | n/a | n/a | n/a | n/a |
| Purchase of Investments | -11.88M | -36.80M | -79.08M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 67.67M | 60.50M | 121.00K | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 23.70M | -121.00K | n/a | n/a | n/a |
| Investing Cash Flow | 55.78M | 23.69M | -79.17M | -74.00K | -4.00K | n/a |
| Debt Repayment | -1.62M | n/a | 220.00K | n/a | 4.49M | n/a |
| Common Stock Repurchased | n/a | -40.00K | 134.00K | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -2.85M | -201.00K | 423.00K | 87.68M | 7.94M | n/a |
| Financial Cash Flow | 49.14M | -241.00K | 643.00K | 181.03M | 12.43M | n/a |
| Net Cash Flow | 71.64M | -18.23M | -114.40M | 153.44M | -188.00K | -8.57M |
| Free Cash Flow | -33.28M | -41.69M | -35.97M | -27.59M | -12.62M | -8.57M |